Publication: Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, ras wild-type, metastatic colon cancer: A multicenter onco-colon Turkey study
dc.contributor.author | Arslan, C. | |
dc.contributor.author | Kefeli, U. | |
dc.contributor.author | Yildirim, E. | |
dc.contributor.author | Isikdogan, A. | |
dc.contributor.author | Karadurmus, N. | |
dc.contributor.author | Karabulut, B. | |
dc.contributor.author | Cicin, I. | |
dc.contributor.author | Bilir, C. | |
dc.contributor.author | Ozcelik, M. | |
dc.contributor.author | Cil, T. | |
dc.contributor.author | Celik, S. | |
dc.contributor.author | Bozkurt, O. | |
dc.contributor.author | Harputluoglu, H. | |
dc.contributor.author | Oven, B. | |
dc.contributor.author | Geredeli, C. | |
dc.contributor.author | Tural, D. | |
dc.contributor.author | Sakin, A. | |
dc.contributor.author | Cevik, D. | |
dc.contributor.author | Gumus, M. | |
dc.contributor.author | Yalcin, S. | |
dc.contributor.buuauthor | Çubukcu, E. | |
dc.contributor.buuauthor | ÇUBUKÇU, ERDEM | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi. | |
dc.contributor.orcid | 0000-0002-7584-3868 | |
dc.contributor.orcid | 0000-0002-1372-4791 | |
dc.contributor.orcid | 0000-0001-6906-7500 | |
dc.contributor.orcid | 0000-0002-3982-7465 | |
dc.contributor.orcid | 0000-0003-3550-9993 | |
dc.contributor.orcid | 0000-0002-1618-1147 | |
dc.contributor.researcherid | HTO-4176-2023 | |
dc.contributor.researcherid | I-1932-2016 | |
dc.contributor.researcherid | A-2491-2017 | |
dc.date.accessioned | 2024-06-25T05:38:11Z | |
dc.date.available | 2024-06-25T05:38:11Z | |
dc.date.issued | 2021-07-03 | |
dc.description | Bu çalışma, 30 Haziran - 03 Temmuz 2021 tarihleri arasında düzenlenen 23. ESMO World Congress on Gastrointestinal Cance’da bildiri olarak sunulmuştur. | |
dc.description.sponsorship | ESMO | |
dc.description.sponsorship | Amgen Pharmaceuticals | |
dc.identifier.doi | 10.1016/j.annonc.2021.05.273 | |
dc.identifier.endpage | S174 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issue | Supplement 3 | |
dc.identifier.startpage | S174 | |
dc.identifier.uri | https://doi.org/10.1016/j.annonc.2021.05.273 | |
dc.identifier.uri | https://hdl.handle.net/11452/42309 | |
dc.identifier.volume | 32 | |
dc.identifier.wos | 000670004200217 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.ISTP | |
dc.language.iso | en | |
dc.publisher | Elsevier | |
dc.relation.journal | Annals Of Oncology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Oncology | |
dc.subject | Oncology | |
dc.title | Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, ras wild-type, metastatic colon cancer: A multicenter onco-colon Turkey study | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | f971677f-09c5-4463-bf01-3c6341fbe5f7 | |
relation.isAuthorOfPublication.latestForDiscovery | f971677f-09c5-4463-bf01-3c6341fbe5f7 |